Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study.

G V Papamichail Athanasios Georgiadis Constantinos Tellis I Rapti Theodora E Markatseli V G Xydis Alexandros D Tselepis Alexandros A Drosos Paraskevi Vasileios Voulgari

Published in: Clinical rheumatology (2023)

We provide evidence that atherogenic lipid profile and ongoing atherosclerosis which characterize RA patients appear to improve after biological therapy, and we also suggest a possible atherogenic effect of IgG anti-ox LDL antibodies.

Keyphrases

low density lipoprotein
rheumatoid arthritis
end stage renal disease
cardiovascular disease
newly diagnosed
ejection fraction
disease activity
chronic kidney disease
prognostic factors
type diabetes
stem cells
systemic lupus erythematosus
mesenchymal stem cells
patient reported